Publication Date
March 2024
USD 6.85 billion
USD 10.18 billion
USD 7.24 billion
Antacids Market by Drug Class (Acid Neutralizers, H2 Antagonist, Promotility Agents), Formulation (Liquid, Powder, Tablet), Indication, Distribution Channel - Global Forecast 2024-2030

[183 Pages Report] The Antacids Market size was estimated at USD 6.85 billion in 2023 and expected to reach USD 7.24 billion in 2024, at a CAGR 5.81% to reach USD 10.18 billion by 2030.

Antacids Market
To learn more about this report, request a free sample copy

Antacid is a type of medication that is used to neutralize stomach acidity and alleviate symptoms associated with excess gastric acid. These include conditions such as heartburn, indigestion, and stomach upset, providing relief by increasing the pH balance in the stomach. The antacid products are available in various forms, including tablets, liquids, and powders to relieve symptoms associated with gastroesophageal reflux disease (GERD), heartburn, and peptic ulcers. The rising prevalence of GERD, heartburn, and other gastric ailments globally is driving the need for antacid products. Modern dietary habits and lifestyles contribute to increased incidences of acidity and related disorders, further propelling the demand for antacids. Continuous research and development aimed at enhancing product efficacy and reducing side effects positively impact market growth. However, stringent regulations regarding the approval and marketing of antacid products can delay product launches, hampering market growth. The availability of alternative therapies and treatments for acid-related disorders poses a significant challenge for market growth. Moreover, ongoing research into natural and organic ingredients can effectively relieve acidity and related conditions, creating opportunities for market growth. Ongoing innovation in drug delivery technologies to improve the efficacy and duration of action of antacid products, generating growth potential in the market.

Antacids Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
Drug Class: Increasing preference for acid neutralizers for improved therapeutic action

Acid neutralizers, known as antacids, offer quick relief of heartburn and mild symptoms of acid reflux by neutralizing stomach acid. Aluminum hydroxide acts quickly to lower stomach acid; however, its effect is short-lived. It can cause constipation, which might be balanced by combining it with magnesium hydroxide. Calcium carbonate is a potent and fast-acting acid neutralizer and serves as a dietary supplement for calcium. Overuse may lead to constipation or, conversely, diarrhea. Magnesium hydroxide is known for its mild effects and is preferred for its balanced action as an antacid and laxative, making it a common choice for long-term management of acid reflux. Sodium bicarbonate is a fast-acting, potent antacid that offers quick relief from acid reflux. H2 antagonists, or H2 receptor blockers, reduce the production of stomach acid by blocking histamine in the stomach lining cells. This class of drugs is used to treat conditions such as peptic ulcers and gastroesophageal reflux disease (GERD). Promotility agents help increase the movement of the stomach and intestines, assisting in the faster clearance of stomach contents. Promotility agents are used in combination with other antacid therapies to manage GERD and other digestive disorders. Proton pump inhibitors are the most potent inhibitors of stomach acid production. They act by irreversibly blocking the proton pump in the stomach lining, which is responsible for gastric acid secretion. PPIs are used for the long-term management of GERD, peptic ulcers, and other acid-related disorders.

Indication: Expanding need for antacids for the management of gastroesophageal reflux disease for reducing the acid’s ability to damage the esophageal lining.

Gastroesophageal reflux disease, commonly referred to as GERD, is a chronic condition characterized by the backflow of stomach acid into the esophagus, which leads to symptoms such as regurgitation, heartburn, and discomfort. Antacids can provide temporary relief by neutralizing the acid present in the stomach, reducing the acid’s ability to damage the esophageal lining. Indigestion, or dyspepsia, is a condition marked by persistent or recurrent pain in the upper abdomen. It is accompanied by bloating, belching, and nausea. The causes of indigestion can vary, and antacids effectively reduce the discomfort associated with excess stomach acid, contributing to these symptoms. Peptic ulcer disease (PUD) involves the development of ulcers in the stomach or upper part of the small intestine. These ulcers result in several symptoms, including stomach pain, nausea, and, in severe cases, bleeding. Antacids can provide symptomatic relief from the acid-related discomfort of peptic ulcers; however, comprehensive treatment usually requires additional medication to reduce acid production more effectively and promote healing.

Formulation: Rising preference for liquid antacid due to their already dissolved state, facilitating quicker relief from symptoms

Liquid antacids offer a rapid onset of action due to their already dissolved state, facilitating quicker relief from symptoms including heartburn and indigestion. This formulation is particularly beneficial for individuals facing difficulty swallowing pills or tablets. Liquid antacids contain a combination of ingredients, such as aluminum hydroxide, magnesium hydroxide, and simethicone, to neutralize stomach acid effectively. The liquid form allows for easy dosage adjustments and requires proper storage to maintain stability and effectiveness. Powder antacids are a versatile form of antacid that needs to be mixed with water before ingestion. This formulation allows for rapid action as the powder dissolves quickly, facilitating fast absorption. Powder antacids are suitable for people preferring a customized dosage and can be adjusted easily to meet individual needs. However, the preparation process may be a downside for some users, as it requires an extra step compared to ready-to-consume formulations. Tablet antacids are the most convenient and portable form of antacid, ideal for individuals on the go. They are designed to be chewed or swallowed, slowly releasing the active ingredients to neutralize stomach acid. Tablet antacids are favored for their ease of use, discreet nature, and long shelf life. Furthermore, they may contain various combinations of calcium carbonate, magnesium hydroxide, and other alginates to provide symptom relief.

Distribution Channel: Growing availability of antacids across retail pharmacies that provide instant access to antacids without the need for a prescription

Hospital pharmacies represent a critical distribution channel for antacids, especially for patients currently hospitalized and seeking immediate relief from healthcare facilities. Antacids are prescribed by healthcare professionals in this setting based on the patient's specific condition, offering a personalized approach to treatment. This channel is essential for the distribution of over-the-counter (OTC) and prescription-based antacid formulations, ensuring patient access to necessary medications during their stay in medical institutions. Online pharmacies have emerged as a rapidly growing distribution channel for antacids, catering to the increasing consumer preference for convenience and home delivery services. This channel allows consumers to easily compare prices, read reviews, and receive expert consultations before making a purchase. Online pharmacies offer a wide range of antacid products, including those that may not be readily available in traditional retail settings. The rise of e-pharmacy platforms has significantly expanded the reach of antacid products to wider demographics, including remote or underserved areas. Retail pharmacies remain a significant distribution channel for antacid medications, with their widespread presence and accessibility to the general public. These establishments include small, independently owned pharmacies and large pharmacy chains. Retail pharmacies provide instant access to antacids without the need for a prescription, catering to the immediate needs of consumers seeking relief from gastrointestinal discomfort. In-store pharmacists offer additional value by providing guidance and answering queries about antacid products, enhancing the overall customer experience and promoting informed purchase decisions.

Regional Insights

In the Americas region, the antacids market is driven by a high prevalence of gastroesophageal reflux disease (GERD) and stress-induced gastritis, amongst other digestive disorders. Consumer preferences lean toward fast-acting, flavored, and chewable forms in major countries such as the United States and Canada. The EMEA region presents a diverse landscape for antacids as the EU countries prioritize medically proven, prescription-based treatments due to stringent regulations. The EMEA market is characterized by a strong presence of global pharmaceutical brands and a growing interest in antacids that offer additional health benefits, such as probiotics. The antacids market in the Middle East and Africa is expanding, driven by lifestyle diseases and an increasing preference for self-medication. Moreover, in the APAC region, the burgeoning middle-class population and increased healthcare spending in China and India are expanding the adoption of antacids in the region. The rising aging population in Japan and a strong focus on preventive healthcare bolster the use of antacids in the APAC region. The domestic antacids market in India is propelled by lifestyle changes, increased fast food consumption, and rising awareness of over-the-counter (OTC) remedies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antacids Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antacids Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • TUMS Teams Up with DraftKings and Desus Nice to Launch TUMS Prop Bites, Allowing Big Game Fans to Go All In on Food for the First Time

    TUMS partners with DraftKings to introduce an innovative platform, TUMS Prop Bites. This unique initiative creates awareness about making free food predictions by offering a chance to compare their selections with others nationwide. The brand's antacid tablets and chews are crafted to immediately relieve heartburn. These chewable solutions address symptoms such as heartburn, acid indigestion, sour stomach, and discomfort. [Published On: 2024-01-17]

  • Dexcel Pharma Acquires 8 OTC Brands to Strengthen its Consumer Healthcare Portfolio

    Dexcel Pharma Ltd. announced its strategic acquisition of eight reputable over-the-counter (OTC) brands to diversify and strengthen its consumer healthcare offerings. The enhanced portfolio features well-known products such as EarCalm Spray, Sominex for sleep assistance, Wind-Eze as an antacid, Bisodol for indigestion relief, Cymex for cold sore treatment, Liberize for erectile dysfunction, Yeast Vite supplements, and MacKenzies Smelling Salts for catarrh and colds. [Published On: 2024-01-11]

  • Camber Pharmaceuticals Launches Generic Wellbutrin SR

    Camber Pharmaceuticals expanded its product line by introducing Famotidine Powder for oral suspension, USP, a treatment developed to address various gastrointestinal conditions. Suitable for adults, this formulation effectively treats active duodenal and gastric ulcers, relieving the symptoms of non-erosive gastroesophageal reflux disease (GERD). [Published On: 2023-11-27]

Key Company Profiles

The report delves into recent significant developments in the Antacids Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aero Healthcare AU Pty Ltd, Alcon Industries, Alkem Laboratories Ltd., Allegiant Health, AstraZeneca plc, Bayer AG, Biocon Limited, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited, Camber Pharmaceuticals, Inc., Cipla Limited, Daiichi Sankyo Company Limited, Dexcel Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Haleon PLC, Imerys S.A., J. B. Chemicals & Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Magmit Pharmaceutical Co., Ltd., Mankind Pharma Ltd., Marksans Pharma, Nestlé S.A., Novartis AG, Perrigo Company plc, Pfizer Inc., Raritan Pharmaceuticals, Inc., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Swiss Chem Healthcare by Swastik Lifesciences, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., The Procter & Gamble Company, Upsher-Smith Laboratories, LLC by Bora Pharmaceuticals, Wonderbelly, and Zoic Pharmaceuticals Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Antacids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Class
    • Acid Neutralizers
      • Aluminum Hydroxide
      • Calcium Carbonate
      • Magnesium Hydroxide
      • Sodium Bicarbonate
    • H2 Antagonist
    • Promotility Agents
    • Proton Pump Inhibitor
  • Formulation
    • Liquid
    • Powder
    • Tablet
  • Indication
    • Gastroesophageal Reflux Disease
    • Indigestion/Dyspepsia
    • Peptic Ulcer Disease
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Antacids Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antacids Market?
  3. What are the technology trends and regulatory frameworks in the Antacids Market?
  4. What is the market share of the leading vendors in the Antacids Market?
  5. Which modes and strategic moves are suitable for entering the Antacids Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Antacids Market, by Drug Class
  7. Antacids Market, by Formulation
  8. Antacids Market, by Indication
  9. Antacids Market, by Distribution Channel
  10. Americas Antacids Market
  11. Asia-Pacific Antacids Market
  12. Europe, Middle East & Africa Antacids Market
  13. Competitive Landscape
  14. Competitive Portfolio
Companies Mentioned
  • Abbott Laboratories
  • Aero Healthcare AU Pty Ltd
  • Alcon Industries
  • Alkem Laboratories Ltd.
  • Allegiant Health
  • AstraZeneca plc
  • Bayer AG
  • Biocon Limited
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Limited
  • Camber Pharmaceuticals, Inc.
  • Cipla Limited
  • Daiichi Sankyo Company Limited
  • Dexcel Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Haleon PLC
  • Imerys S.A.
  • J. B. Chemicals & Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Magmit Pharmaceutical Co., Ltd.
  • Mankind Pharma Ltd.
  • Marksans Pharma
  • Nestlé S.A.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Raritan Pharmaceuticals, Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Swiss Chem Healthcare by Swastik Lifesciences
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • The Procter & Gamble Company
  • Upsher-Smith Laboratories, LLC by Bora Pharmaceuticals
  • Wonderbelly
  • Zoic Pharmaceuticals Pvt. Ltd.
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Antacids Market
The Global Antacids Market size was estimated at USD 6.85 billion in 2023 and expected to reach USD 7.24 billion in 2024.
The Global Antacids Market to grow USD 10.18 billion by 2030, at a CAGR of 5.81%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.